NeuBase Therapeutics
Stock Forecast, Prediction & Price Target
NeuBase Therapeutics Financial Estimates
NeuBase Therapeutics Revenue Estimates
NeuBase Therapeutics EBITDA Estimates
NeuBase Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2020 | 9/30/2021 | 9/30/2022 | 9/30/2026 | 9/30/2027 | ||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $6M Low: $6M High: $6M avg. 0% | Avg: $152.2K Low: $152.2K High: $152.2K avg. -97.46% | ||
Net Income
% change YoY
| $-17.26M N/A | $-25.66M -48.69% | $-34.23M -33.37% | Avg: $-20.51M Low: $-2.55M High: $-2.55M avg. 40.08% | Avg: $-3.00M Low: $-3.00M High: $-3.00M avg. 85.34% | ||
EBITDA
% change YoY
| $-16.91M N/A | $-25.92M -53.21% | $-32.48M -25.32% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
EPS
% change YoY
| -$17.6 N/A | -$18.8 -6.81% | -$21.08 -12.12% | Avg: -$1.57 Low: -$1.57 High: -$1.57 avg. 92.55% | Avg: -$1.85 Low: -$1.85 High: -$1.85 avg. -17.83% | ||
Operating Expenses
% change YoY
| $17.06M N/A | $26.56M 55.63% | $33.31M 25.41% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
FAQ
What is NeuBase Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 62.71% in 2026-2027.
We have gathered data from 1 analysts. Their low estimate is -2.55M, average is -20.51M and high is -2.55M.
What is NeuBase Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -48.73% in 2026-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $6M, average is $6M and high is $6M.
What is NeuBase Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 37.35% in 2026-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.57, average is -$1.57 and high is $-1.57.